Review
Aug 2026
Bispecific Antibody-Drug Conjugates in Oncology: Design Principles, Clinical Progress, and Challenges
Contin improvements in antibody engineering, linker optimization, payload development, computational modeling, and biomarker-guided patient selection are expected to further improve the therapeutic index and translational success of bsADCs in cancer treatment.
Vaishali Verma, Nimisha Sinha, Abhishek Kasana
· Current Pharmacology Reports · 0 citations